ZVRA vs. CRMD
ZVRA (Zevra Therapeutics Inc.) and CRMD (CorMedix Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ZVRA returned -17.62%/yr vs 0.24%/yr for CRMD. Their 0.21 correlation means their historical movements had little consistent relationship.
Performance
ZVRA vs. CRMD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZVRA achieves a 6.14% return, which is significantly higher than CRMD's -35.25% return. Over the past 10 years, ZVRA has underperformed CRMD with an annualized return of -17.62%, while CRMD has yielded a comparatively higher 0.24% annualized return.
ZVRA
- 1D
- -1.35%
- 1M
- -31.14%
- 6M
- 5.67%
- YTD
- 6.14%
- 1Y
- -14.40%
- 3Y*
- 24.74%
- 5Y*
- -1.18%
- 10Y*
- -17.62%
- ALL TIME*
- -23.23%
CRMD
- 1D
- 0.53%
- 1M
- -11.10%
- 6M
- -2.96%
- YTD
- -35.25%
- 1Y
- -35.48%
- 3Y*
- 20.63%
- 5Y*
- 5.32%
- 10Y*
- 0.24%
- ALL TIME*
- -4.54%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
CRMD CorMedix Inc. | $7.65M | $7.49M | $10.66M |
| $18.33M | $18.68M | $21.76M |
ZVRA vs. CRMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ZVRA Zevra Therapeutics Inc. | 6.14% | 7.43% | 27.33% | 42.70% | -47.30% | -22.23% | 84.70% | -78.71% | -56.05% | 37.29% |
CRMD CorMedix Inc. | -35.25% | 43.58% | 115.43% | -10.90% | -7.25% | -38.76% | 2.06% | 12.87% | 158.00% | -67.32% |
Correlation
The correlation between ZVRA and CRMD is 0.29, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.29 |
Correlation (3Y) Balances recent behavior with more history. | 0.26 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.31 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.21 |
Correlation (All Time) Calculated using the full available price history since Apr 16, 2015 | 0.21 |
Fundamentals
ZVRA:
$562.18M
CRMD:
$590.74M
ZVRA:
$2.15
CRMD:
$1.99
ZVRA:
4.43
CRMD:
3.79
ZVRA:
4.50
CRMD:
1.71
ZVRA:
2.78
CRMD:
1.60
ZVRA:
$122.29M
CRMD:
$400.05M
ZVRA:
$104.94M
CRMD:
$343.39M
ZVRA:
$149.15M
CRMD:
$207.97M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZVRA vs. CRMD — Risk / Return Rank
ZVRA
CRMD
ZVRA vs. CRMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Zevra Therapeutics Inc. (ZVRA) and CorMedix Inc. (CRMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZVRA | CRMD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.34 | ||
| Sortino ratioReturn per unit of downside risk | +0.58 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 0.94 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | -0.36 | -0.62 | +0.26 |
| Martin ratioReturn relative to average drawdown | -0.65 | -0.90 | +0.25 |
Loading charts...
Drawdowns
ZVRA vs. CRMD - Drawdown Comparison
The maximum ZVRA drawdown since its inception was -99.27%, roughly equal to the maximum CRMD drawdown of -98.28%. Use the drawdown chart below to compare losses from any high point for ZVRA and CRMD.
Loading charts...
Drawdown Indicators
| ZVRA | CRMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.27% | -98.28% | -0.99% |
Max Drawdown (1Y)Largest decline over 1 year | -40.40% | -57.86% | +17.46% |
Max Drawdown (3Y)Largest decline over 3 years | -43.47% | -62.26% | +18.79% |
Max Drawdown (5Y)Largest decline over 5 years | -60.97% | -62.63% | +1.66% |
Max Drawdown (10Y)Largest decline over 10 years | -97.85% | -94.77% | -3.08% |
Current DrawdownCurrent decline from peak | -97.48% | -84.74% | -12.74% |
Average DrawdownAverage peak-to-trough decline | -86.53% | -77.60% | -8.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.22% | 39.35% | -17.13% |
Volatility
ZVRA vs. CRMD - Volatility Comparison
Zevra Therapeutics Inc. (ZVRA) has a higher volatility of 29.44% compared to CorMedix Inc. (CRMD) at 13.70%. This indicates that ZVRA's price experiences larger fluctuations and is considered to be riskier than CRMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZVRA | CRMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.44% | 13.70% | +15.74% |
Volatility (6M)Calculated over the trailing 6-month period | 49.17% | 32.59% | +16.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 65.35% | 63.84% | +1.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 61.11% | 77.16% | -16.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.05% | 91.61% | -10.56% |
Dividends
ZVRA vs. CRMD - Dividend Comparison
Neither ZVRA nor CRMD has paid dividends to shareholders.
Financials
ZVRA vs. CRMD - Financials Comparison
This section allows you to compare key financial metrics between Zevra Therapeutics Inc. and CorMedix Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ZVRA and CRMD have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZVRA has higher volatility (29.44%) compared to CRMD (13.70%). In terms of maximum drawdown, ZVRA dropped -99.27% vs CRMD's -98.28%.
ZVRA currently has the higher Sharpe Ratio (-0.22 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZVRA and CRMD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer